Murine and math models for the level of stable mixed chimerism to cure β-thalassemia by nonmyeloablative bone marrow transplantation

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 423-428

  Roberts, Carla ^a   Kean, Leslie ^b   Archer, David ^b   Balkan, Can ^c   Hsu, Lewis L ^d,e  

^a Palmetto Richland Memorial Hospital   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow transplant; Chimerism; Hemolytic anemia; Mathematical model; Moose model; Nonmyeloablative transplant; Sickle cell; Thalassemia

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BETA THALASSEMIA; CELL LINEAGE; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; DONOR; ERYTHROCYTE LIFESPAN; HEMOLYTIC ANEMIA; LEUKOCYTE; MATHEMATICAL MODEL; MOUSE; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PHENOTYPE; STABLE MIXED CHIMERISM; STEADY STATE; SURVIVAL; TREATMENT OUTCOME; WILD TYPE;

ANIMALIA; MURINAE;

EID: 29744468974     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.061     Document Type: Conference Paper

References (10)

1. ANDREANI, M., M. MANNA, S. NESCI, et al. 1991. Persistence of mixed chimerism in class 3 thalassemic patients following BMT. Bone Marrow Transplant. 7(Suppl. 2): 75.
2. ANDREANI, M., S. NESCI, G. LUCARELLI, et al. 2000. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. 25: 401-404.
3. WALTERS, M.C., M. PATIENCE, W. LEISENRING, et al. 2001. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant. 7: 665-673.
4. VAN DEN BOS, C., D. KIEBOOM & G. WAGEMAKER. 1993. Correction of murine beta-thalassemia by partial bone marrow chimerism: selective advantage of normal erythropoiesis. Bone Marrow Transplant. 12: 9-13.
5. WEST, C., L. KEAN, D. ARCHER & L.L. HSU. 2001. A cure for murine beta-thalassemia (β-THAL) through stable mixed chimerism after nonmyeloablative bone marrow transplantation (BMT). Presented at the American Society of Hematology Conference: Blood. Orlando, FL.
6. HSU, L., C. WEST, L. KEAN & D. ARCHER. 2001. Predicting partial mixed chimerism in hemoglobinopathy transplant: a proposed simple math model. Presented at the American Society of Hematology Conference; Blood. Orlando, FL.
7. HSU, L.L. & Y.Y. HSU. 2005. Mathematical model of blood cell survival advantage in partial mixed chimerism. In preparation.
8. IANNONE, R., J.F. CASELLA, E.J. FUCHS, et al. 2003. Results of minimally toxic non-myeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol. Blood Marrow Transplant. 9: 519-528.
9. BRADLEY, M.B., R.M. SATTLER, H. RAFTOPOULOS, et al. 2002. Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen. Biol. Blood Marrow Transplant. 8: 453-461.
10. PERSONS, D.A., E.R. ALLAY, D.E. SABATINO, et al. 2001. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy. Blood 97: 3275-3282.